About Event

6th Annual Allogeneic Cell Therapies Summit – What’s It About?

2024 is shaping up to be a vitally important year for the future of allogeneic cell therapies. With exciting clinical data readouts expected in the coming months and the cell therapy community recognizing autoimmune indications as the promising new cornerstone of research – the tide is shifting for off-the-shelf therapies.

Leaders from Caribou Biosciences, Atara Biotherapeutics, Adicet Bio and many more are speaking at the 6th Annual Allogeneic Cell Therapies Summit to share their exciting pipeline developments and best practices when it comes to novel modifications for allogeneic cells, platforms to allow upscaling of manufacturing and to understanding which new disease indications will benefit from your universal cell products.

Don’t miss this golden opportunity to connect with other cell therapy leaders to accelerate your allogeneic pipelines in 2024 and beyond!

View the Full Agenda Now

Brochure front cover ss

“It was time well spent, good presentations and generated new inspiration”

Glycostem Therapeutics

Top Reasons to Attend:

Allo Stickers - Icons 4

Explore the broadening applications of off-the-shelf therapies in autoimmune conditions with expert speakers from MiNK Therapeutics, Bayer and Cabaletta

Allo Stickers - Icons 2

Hear the exciting clinical progress being made in the field with data presentations from Caribou Bio, Poseida Therapeutics, Adicet Bio and Sanofi

Allo Stickers - Icons 5

Learn how to make the most of automation and agile process development to upscale your manufacturing capabilities with ImmuneBridge and Stempeutics

Allo Stickers - Icons 3

Prioritize business development and forge new partnerships with 8-hours of dedicated networking with a community that share common interests and goals

Allo Stickers - Icons 1

Implement effective donor selection and management after hearing talks from IN8Bio, Cellectis and Beam Therapeutics

Allo Stickers - Icons 6

Engage with new biotech startups and biopharma companies that are now pivoting off-the-shelf therapies with 12+ all-new companies making their presentation debut at this summit

“Great place to meet a focused audience from the allogeneic therapies field”


Other Events in the Series: